Gina Consylman appointed main economic officer, critical genetic disease
Marcela Maus named to bluebird bio board of directors
bluebird bio and 2seventy bio to keep trader functions in September in progress of separation
Small business separation targeted for October 2021 completion
CAMBRIDGE, Mass., September 07, 2021–(Small business WIRE)–bluebird bio, Inc. (NASDAQ: BLUE) today announced crucial administration and board appointments in advance of the company’s prepared separation, qualified for mid-Oct, 2021. The business also outlined options for trader situations and participation in investor conferences main up to the separation.
“As we solution separation, we are centered on